Genetically Engineered Cell Lines

With the advancement of gene sequencing and gene editing technologies, an increasing number of new drug targets for cancer are being discovered. Drug testing at the cellular level targeting these new targets is a crucial step in drug discovery. Our expert team has over 20 years of experience in engineering cell lines. We have already constructed over 4,000 genetically edited cell lines, covering a wide range of overexpressed, knocked-in, and knocked-out genes related to kinase (based on BaF3 cell line), signaling pathways, immune molecules, tumor antigens, etc. These cell lines support the development of both small molecule and antibody-based drugs for cancer treatment.